OSMR and ovarian cancer: In consistent with mRNA data, protein levels of OSMR and its dimerizing partner IL6ST are highly upregulated in cisplatin-resistant A2780, OVCAR8, PEO4 and MCW-OV-SL3 ovarian cancer cell lines compared to their respective controls (Fig. 1f).